Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers ...Middle East

- News
Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers
A high rate of genetic mutations within a tumor, known as high tumor mutation burden, was only useful for predicting immunotherapy responses in a subset of cancer types, suggesting that this may not reliably be used as a universal biomarker.

Hence then, the article about study finds high tumor mutation burden predicts immunotherapy response in some but not all cancers was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers )

Apple Storegoogle play

Last updated :

Also on site :